Amplification of c-erbB2 oncogene : A major prognostic indicator in uterine serous papillary carcinoma
- Author
- SANTIN, Alessandro D1 ; BELLONE, Stefania1 ; VAN STEDUM, Sue2 ; BUSHEN, Wendy2 ; PALMIERI, Michela3 ; SIEGEL, Eric R4 ; DE LAS CASAS, Luis E5 ; ROMAN, Juan J1 ; BURNETT, Alexander1 ; PECORELLI, Sergio3
[1] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
[2] Research and Development, Vysis, Inc. (Abbott Molecular Diagnostics), Downers Grove, Illinois, United States
[3] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Brescia, Brescia, Italy
[4] Department of Biostatistics, University of Arkan sas for Medical Sciences, Little Rock, Arkansas, United States
[5] Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States - Source
Cancer. 2005, Vol 104, Num 7, pp 1391-1397, 7 p ; ref : 34 ref
- CODEN
- CANCAR
- ISSN
- 0008-543X
- Scientific domain
- Medical oncology
- Publisher
- Wiley-Liss, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- HER-2/neu Herceptin PathVysion c-erbB2 fluorescence in situ hybridization uterine serous papillary carcinoma
- Keyword (fr)
- Amplification Anticancéreux Anticorps monoclonal Cancérologie Carcinome séreux papillaire Gène erbB2 Gène onc cellulaire Gène onc Hybridation in situ fluorescence Indicateur Pronostic Protooncogène Trastuzumab Récepteur HER2 Anticytokine
- Keyword (en)
- Amplification Antineoplastic agent Monoclonal antibody Cancerology Papillary serous carcinoma erbB2 Gene C-Onc gene Onc gene Fluorescence in situ hybridization Indicator Prognosis Protooncogene Trastuzumab Human Epidermal growth factor Receptor 2 Anticytokine
- Keyword (es)
- Amplificación Anticanceroso Anticuerpo monoclonal Cancerología Carcinoma seroso papilar Gen erbB2 Gen onc celular Gen onc Hibridación in situ fluorescencia Indicador Pronóstico Protooncogen Trastuzumab Anticitoquina
- Classification
- Discipline
- Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17136946
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:102:\"Amplification of c-erbB2 oncogene : A major prognostic indicator in uterine serous papillary carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:3:\"104\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1391\";s:8:\"\u0000*\u0000epage\";s:4:\"1397\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"SANTIN\";s:10:\"\u0000*\u0000aufirst\";s:12:\"Alessandro D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:17:\"BELLONE, Stefania\";i:1;s:15:\"VAN STEDUM, Sue\";i:2;s:13:\"BUSHEN, Wendy\";i:3;s:17:\"PALMIERI, Michela\";i:4;s:14:\"SIEGEL, Eric R\";i:5;s:20:\"DE LAS CASAS, Luis E\";i:6;s:13:\"ROMAN, Juan J\";i:7;s:18:\"BURNETT, Alexander\";i:8;s:17:\"PECORELLI, Sergio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:102:\"Amplification of c-erbB2 oncogene : A major prognostic indicator in uterine serous papillary carcinoma\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:102:\"Amplification of c-erbB2 oncogene : A major prognostic indicator in uterine serous papillary carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:3:\"104\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1391\";s:8:\"\u0000*\u0000epage\";s:4:\"1397\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"SANTIN\";s:10:\"\u0000*\u0000aufirst\";s:12:\"Alessandro D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:17:\"BELLONE, Stefania\";i:1;s:15:\"VAN STEDUM, Sue\";i:2;s:13:\"BUSHEN, Wendy\";i:3;s:17:\"PALMIERI, Michela\";i:4;s:14:\"SIEGEL, Eric R\";i:5;s:20:\"DE LAS CASAS, Luis E\";i:6;s:13:\"ROMAN, Juan J\";i:7;s:18:\"BURNETT, Alexander\";i:8;s:17:\"PECORELLI, Sergio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:102:\"Amplification of c-erbB2 oncogene : A major prognostic indicator in uterine serous papillary carcinoma\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:102:\"Amplification of c-erbB2 oncogene : A major prognostic indicator in uterine serous papillary carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:3:\"104\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1391\";s:8:\"\u0000*\u0000epage\";s:4:\"1397\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"SANTIN\";s:10:\"\u0000*\u0000aufirst\";s:12:\"Alessandro D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:17:\"BELLONE, Stefania\";i:1;s:15:\"VAN STEDUM, Sue\";i:2;s:13:\"BUSHEN, Wendy\";i:3;s:17:\"PALMIERI, Michela\";i:4;s:14:\"SIEGEL, Eric R\";i:5;s:20:\"DE LAS CASAS, Luis E\";i:6;s:13:\"ROMAN, Juan J\";i:7;s:18:\"BURNETT, Alexander\";i:8;s:17:\"PECORELLI, Sergio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:102:\"Amplification of c-erbB2 oncogene : A major prognostic indicator in uterine serous papillary carcinoma\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:102:\"Amplification of c-erbB2 oncogene : A major prognostic indicator in uterine serous papillary carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:3:\"104\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1391\";s:8:\"\u0000*\u0000epage\";s:4:\"1397\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"SANTIN\";s:10:\"\u0000*\u0000aufirst\";s:12:\"Alessandro D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:17:\"BELLONE, Stefania\";i:1;s:15:\"VAN STEDUM, Sue\";i:2;s:13:\"BUSHEN, Wendy\";i:3;s:17:\"PALMIERI, Michela\";i:4;s:14:\"SIEGEL, Eric R\";i:5;s:20:\"DE LAS CASAS, Luis E\";i:6;s:13:\"ROMAN, Juan J\";i:7;s:18:\"BURNETT, Alexander\";i:8;s:17:\"PECORELLI, Sergio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:102:\"Amplification of c-erbB2 oncogene : A major prognostic indicator in uterine serous papillary carcinoma\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
